MX2017011116A - Composiciones novedosas, usos y metodos para hacerlas. - Google Patents
Composiciones novedosas, usos y metodos para hacerlas.Info
- Publication number
- MX2017011116A MX2017011116A MX2017011116A MX2017011116A MX2017011116A MX 2017011116 A MX2017011116 A MX 2017011116A MX 2017011116 A MX2017011116 A MX 2017011116A MX 2017011116 A MX2017011116 A MX 2017011116A MX 2017011116 A MX2017011116 A MX 2017011116A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- making
- novel compositions
- present
- compounds
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000007660 quinolones Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562128208P | 2015-03-04 | 2015-03-04 | |
| PCT/US2016/020418 WO2016141042A2 (en) | 2015-03-04 | 2016-03-02 | Novel compositions, uses and methods for making them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017011116A true MX2017011116A (es) | 2018-05-28 |
Family
ID=56848519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017011116A MX2017011116A (es) | 2015-03-04 | 2016-03-02 | Composiciones novedosas, usos y metodos para hacerlas. |
Country Status (7)
| Country | Link |
|---|---|
| US (9) | US9758518B2 (enExample) |
| EP (1) | EP3300501A4 (enExample) |
| JP (2) | JP6878288B2 (enExample) |
| CN (1) | CN107567448B (enExample) |
| CA (1) | CA2978571C (enExample) |
| MX (1) | MX2017011116A (enExample) |
| WO (1) | WO2016141042A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9758518B2 (en) | 2015-03-04 | 2017-09-12 | Pimera, Inc. | Compositions, uses and methods for making them |
| CN106588920B (zh) * | 2016-12-27 | 2018-10-30 | 云南大学 | 1,3-二氮杂环并[1,2-a]喹啉类化合物及其制备方法和抗肿瘤应用 |
| EP3601286A4 (en) * | 2017-03-28 | 2020-09-23 | Pimera, Inc. | NEW CRYSTALLINE FORMS OF A POL1 INHIBITOR |
| WO2020160174A1 (en) * | 2019-01-29 | 2020-08-06 | Universita Degli Studi Di Padova | Uses of compounds having anti-hsv-1 activity |
| US10947253B2 (en) | 2019-08-05 | 2021-03-16 | Ankh Life Sciences Limited | Fused polycyclic dimers |
| US12129265B2 (en) | 2020-07-21 | 2024-10-29 | Ankh Life Sciences Limited | Therapeutic agents and uses thereof |
| US12173005B1 (en) | 2023-12-21 | 2024-12-24 | King Faisal University | Pyrimido[1′,6′:1,5]pyrazolo[4,3-b][1,7]naphthyridine compounds as CK2 inhibitors |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1042801A (en) | 1909-10-28 | 1912-10-29 | Isidor Kitsee | Protecting kinematographic films. |
| NL7709746A (nl) | 1976-09-09 | 1978-03-13 | Hoechst Ag | Werkwijze ter bereiding van benzimidazo-(1,2-a)-chi- nolinen. |
| DE2929414A1 (de) | 1979-07-20 | 1981-02-05 | Hoechst Ag | Pyrimido- eckige klammer auf 5',4' zu 5,6 eckige klammer zu -pyrido- eckige klammer auf 1,2-a eckige klammer zu -benzimidazole, verfahren zu ihrer herstellung und deren verwendung |
| DE3502689A1 (de) | 1985-01-26 | 1986-07-31 | Hoechst Ag, 6230 Frankfurt | Elektrophotographisches aufzeichnungsmaterial |
| DE19509043A1 (de) | 1995-03-03 | 1996-09-05 | Bayer Ag | Cyanierung von Doppelbindungssystemen |
| US5624677A (en) | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
| US6960585B2 (en) | 2000-10-03 | 2005-11-01 | Bristol-Myers Squibb Company | Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
| US7507727B2 (en) | 2003-04-07 | 2009-03-24 | Cylene Pharmaceuticals, Inc. | Substituted quinobenzoxazine analogs and methods of using thereof |
| US7354916B2 (en) | 2003-04-07 | 2008-04-08 | Cylene Pharmaceuticals | Substituted quinobenzoxazine analogs |
| NZ543006A (en) | 2003-04-07 | 2009-03-31 | Cylene Pharmaceuticals Inc | Substituted quinobenzoxazine analogs |
| AU2005286965B2 (en) | 2004-09-17 | 2009-10-22 | Senhwa Biosciences, Inc. | Quinolone analogs as cell proliferation inhibitors |
| US7652134B2 (en) | 2004-09-17 | 2010-01-26 | Cylene Pharmaceuticals, Inc. | Methods for converting quinolone esters into quinolone amides |
| US7402579B2 (en) | 2005-04-15 | 2008-07-22 | Cylene Pharmaceuticals, Inc. | Quinobenzoxazine analogs and compositions |
| EP1928887B1 (en) | 2005-08-05 | 2014-12-17 | Senhwa Biosciences, Inc. | Methods of preparing quinolone analogs |
| JP5119154B2 (ja) | 2005-09-22 | 2013-01-16 | インサイト・コーポレイション | Ｊａｎｕｓキナーゼの四環系阻害剤 |
| US8142909B2 (en) | 2006-02-10 | 2012-03-27 | Universal Display Corporation | Blue phosphorescent imidazophenanthridine materials |
| CA2651072A1 (en) | 2006-05-01 | 2007-11-08 | Pfizer Products Inc. | Substituted 2-amino-fused heterocyclic compounds |
| US20100063046A1 (en) | 2006-05-17 | 2010-03-11 | Whitten Jeffrey P | Tetracyclic imidazole analogs |
| DK3092901T3 (da) | 2007-10-05 | 2020-05-18 | Senhwa Biosciences Inc | Quinolonanaloger og fremgangsmåder relateret dertil |
| ES2378513T3 (es) | 2008-08-06 | 2012-04-13 | Pfizer Inc. | Compuestos 2-heterociclilamino piracinas sustituidas en posición 6 como inhibidores de CHK-1 |
| CN102119158B (zh) | 2008-11-03 | 2015-09-09 | 株式会社Lg化学 | 含氮杂环化合物及使用该化合物的有机电子器件 |
| US8124770B2 (en) | 2009-04-01 | 2012-02-28 | Beatriz Zayas | Fluorescent cellular markers |
| CN101781312B (zh) | 2009-12-30 | 2012-09-26 | 中国科学院广州生物医药与健康研究院 | 一种吲哚衍生物的合成方法 |
| US8637529B2 (en) | 2010-06-11 | 2014-01-28 | AbbYie Inc. | Pyrazolo[3,4-d]pyrimidine compounds |
| KR101567610B1 (ko) * | 2010-11-04 | 2015-11-09 | 주식회사 엘지화학 | 신규한 질소 함유 헤테로환 화합물 및 이를 이용한 유기 전자 소자 |
| PE20141359A1 (es) | 2011-10-21 | 2014-10-13 | Glaxosmithkline Llc | Compuestos y metodos para mejorar las respuestas inmunitarias innatas |
| KR101561730B1 (ko) | 2012-02-06 | 2015-10-22 | 주식회사 엘지화학 | 질소원소를 함유한 헤테로고리 유도체 및 이를 이용한 유기 전자 소자 |
| WO2015079411A1 (en) | 2013-11-28 | 2015-06-04 | Tel Hashomer Medical Research Infrastructure And Services Ltd. | Rna polymerase i inhibitors and uses thereof |
| CN106995443B (zh) | 2014-05-09 | 2022-01-11 | 皮梅拉股份有限公司 | 新组合物、用途和制备它们的方法 |
| US9758518B2 (en) | 2015-03-04 | 2017-09-12 | Pimera, Inc. | Compositions, uses and methods for making them |
| CN106349244B (zh) | 2015-07-13 | 2018-07-27 | 首都医科大学 | 苯并咪唑并喹唑啉二甲氧苯氧乙酰-AA-OBzl，其合成，活性和应用 |
| WO2017087235A1 (en) | 2015-11-20 | 2017-05-26 | Senhwa Biosciences, Inc. | Combination therapy of tetracyclic quinolone analogs for treating cancer |
| EP3601286A4 (en) | 2017-03-28 | 2020-09-23 | Pimera, Inc. | NEW CRYSTALLINE FORMS OF A POL1 INHIBITOR |
-
2015
- 2015-11-06 US US14/935,155 patent/US9758518B2/en active Active
-
2016
- 2016-03-02 MX MX2017011116A patent/MX2017011116A/es unknown
- 2016-03-02 WO PCT/US2016/020418 patent/WO2016141042A2/en not_active Ceased
- 2016-03-02 US US15/555,024 patent/US10975076B2/en active Active
- 2016-03-02 CA CA2978571A patent/CA2978571C/en active Active
- 2016-03-02 JP JP2017546121A patent/JP6878288B2/ja active Active
- 2016-03-02 CN CN201680022357.7A patent/CN107567448B/zh active Active
- 2016-03-02 EP EP16759401.9A patent/EP3300501A4/en not_active Withdrawn
-
2017
- 2017-04-11 US US15/485,106 patent/US9951066B2/en active Active
- 2017-07-27 US US15/661,770 patent/US10590134B2/en active Active
-
2018
- 2018-01-08 US US15/864,965 patent/US10442801B2/en active Active
-
2019
- 2019-06-03 US US16/430,129 patent/US10745403B2/en active Active
-
2020
- 2020-01-10 US US16/739,354 patent/US11618752B2/en active Active
- 2020-07-09 US US16/925,220 patent/US11623928B2/en active Active
-
2021
- 2021-02-02 JP JP2021014802A patent/JP2021066741A/ja active Pending
- 2021-03-17 US US17/204,459 patent/US11866438B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018507230A (ja) | 2018-03-15 |
| US9951066B2 (en) | 2018-04-24 |
| US9758518B2 (en) | 2017-09-12 |
| US10975076B2 (en) | 2021-04-13 |
| US20190389860A1 (en) | 2019-12-26 |
| WO2016141042A3 (en) | 2016-11-03 |
| WO2016141042A2 (en) | 2016-09-09 |
| CN107567448A (zh) | 2018-01-09 |
| US11618752B2 (en) | 2023-04-04 |
| US20170334905A1 (en) | 2017-11-23 |
| CA2978571A1 (en) | 2016-09-09 |
| US10745403B2 (en) | 2020-08-18 |
| US20160257678A1 (en) | 2016-09-08 |
| US20190233422A1 (en) | 2019-08-01 |
| US20180291020A1 (en) | 2018-10-11 |
| US10442801B2 (en) | 2019-10-15 |
| US20210094952A1 (en) | 2021-04-01 |
| JP6878288B2 (ja) | 2021-05-26 |
| US20210317120A1 (en) | 2021-10-14 |
| US20200361937A1 (en) | 2020-11-19 |
| EP3300501A4 (en) | 2019-04-17 |
| US11866438B2 (en) | 2024-01-09 |
| US20180079750A1 (en) | 2018-03-22 |
| WO2016141042A4 (en) | 2016-12-15 |
| CA2978571C (en) | 2023-10-03 |
| US10590134B2 (en) | 2020-03-17 |
| JP2021066741A (ja) | 2021-04-30 |
| EP3300501A2 (en) | 2018-04-04 |
| US11623928B2 (en) | 2023-04-11 |
| CN107567448B (zh) | 2021-06-08 |
| HK1247927A1 (zh) | 2018-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12017500660A1 (en) | Novel compositions, uses and methods for making them | |
| PH12018500907A1 (en) | Inhibitors of ret | |
| MX2020005213A (es) | Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos. | |
| HK1255162A1 (zh) | 爱帕琳肽受体激动剂及使用方法 | |
| MY189454A (en) | 6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as apj agonists | |
| MX2018001890A (es) | Compuestos biciclicos como inhibidores de autotaxina (atx). | |
| PH12018500408A1 (en) | Bicyclic compounds as atx inhibitors | |
| SG10201908839QA (en) | 2,4-dihydroxy-nicotinamides as apj agonists | |
| MX2018006632A (es) | Inhibidores biciclicos de peptidilarginina deiminasa 4 (pad4). | |
| NZ763528A (en) | Heterocyclic gpr119 agonist compounds | |
| PH12018500409A1 (en) | New bicyclic compounds as dual atx/ca inhibitors | |
| MX2017001971A (es) | Composiciones antimetanogenicas y sus usos. | |
| WO2015120062A8 (en) | Therapeutic compounds and compositions | |
| MX2017011116A (es) | Composiciones novedosas, usos y metodos para hacerlas. | |
| MX2018004674A (es) | Moduladores de interacción de sestrina-gator2 y sus usos. | |
| MX2017008390A (es) | Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato. | |
| TN2018000057A1 (en) | Compounds useful for inhibiting ror-gamma-t. | |
| PH12016501613A1 (en) | Pyrazines modulators of gpr6 | |
| PH12018500406A1 (en) | Bicyclic compounds as atx inhibitors | |
| PH12018500407A1 (en) | New bicyclic compounds as dual atx/ca inhibitors | |
| MX2016015468A (es) | Composiciones farmaceuticas que contienen montelukast y levocetirizina. | |
| IN2014MU00815A (enExample) | ||
| IN2014MU00814A (enExample) |